Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
Paul Riley, Scientific Marketing Manager at Diagnostica Stago, shared on LinkedIn about his recent article, adding:
”Happy to share a new review article on thrombin generation testing I wrote and recently accepted by Clinics in Laboratory Medicine for a special edition.
The article describes a assay I am very passionate about which has the potential to give clinicians better information about patients’ global risk of bleeding or thrombosis.
The assay is not FDA cleared but available for research in the US and Canada.
It is being used in clinical settings internationally, though in limited volume.
Hopefully usage will increase over time especially if there’s a successful FDA submission at some point.
Thank you to the editors for inviting me to contribute.”
Title: Thrombin Generation Assay: Ready for Prime Time
Authors: Paul Riley
Read the Full Article on Clinics in Laboratory Medicine

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis